Ironwood Pharmaceuticals | IRWD - Gross Profit On Sales


Ironwood Pharmaceuticals reported $85.24M in Gross Profit on Sales for its fiscal quarter ending in June of 2025.





Gross Profit On Sales Change Date
Acadia Pharmaceuticals USD 257.76M 778K Dec/2025
Agios Pharmaceuticals USD 18.09M 6.89M Dec/2025
Akebia Therapeutics USD 49.21M 13.25M Mar/2025
Alnylam Pharmaceuticals USD 829.31M 219.56M Dec/2025
Amarin USD 22.21M 28.15M Sep/2025
Ardelyx USD 106.35M 23.51M Sep/2025
Astellas Pharma JPY 456.81B 38.02B Dec/2025
AstraZeneca USD 12.39B 5M Dec/2025
Charles River Laboratories USD 271.96M 39.43M Dec/2025
Coherus Biosciences USD 4.95M 15.34M Mar/2025
Esperion Therapeutics USD -29.52M 32.4M Sep/2024
Exact Sciences USD 583.93M 21.48M Sep/2025
Halozyme Therapeutics USD 281.77M 2.41M Sep/2025
Incyte USD 1.39B 118.68M Dec/2025
Ironwood Pharmaceuticals USD 85.24M 44.1M Jun/2025
Karyopharm Therapeutics USD -30.78M 1.29M Dec/2024
Lexicon Pharmaceuticals USD -16.16M 2.89M Jun/2024
MacroGenics USD 61.25M 88.71M Sep/2025
Moderna USD 226M 583M Dec/2025
Myriad Genetics USD 143.8M 8M Sep/2025
Pacira USD 142.25M 11.34M Dec/2025
PTC Therapeutics USD 148.38M 39.31M Dec/2025
Puma Biotechnology USD 20.32M 24.85M Sep/2024
Sarepta Therapeutics USD 43.55M 204.36M Dec/2025
Takeda JPY 790.55B 262.97B Dec/2025
Ultragenyx Pharmaceutical USD 178M 46.06M Dec/2025
Vanda Pharmaceuticals USD 50.6M 5.5M Dec/2024